tion may be useful In differentiating hypertrophic cardiomyopathy from hyperteasive hypertrophyMethods . Calibrated myocardial Integrated backscatter and its tr rural gradient were measured in the septum and posterior wall to 31 normal subjects, 13 patients with hypertensioe hypertrophy and 22 patients with bypertrophic cardiomyopathy . The gradient in Integrated backscatter was determined as the ratio or calibrated integrated backscatter in the endocardial half to that in the eplcardlal half of the myocardium .
In addition to the pathologic ventricular hypertrophy seen in patients with hypertrophic cardiomyopathy, ventricular hypertrophy may develop physiologically in patients with hypertension, as an adaptive process to pressure overload (1,2) . Although conventional echocardiography is particularly useful ir1 detecting increased left ventricular mass or abnormal myocardial function, or both, in patients with possible ventricular hypertrophy (3) (4) (5) (6) (7) (8) , the two entities are most clearly differentiated by detection of the presence of myocardial fiber architecture distortion or extremely increased collagen (9) (10) (11) (12) (13) (14) . Thus, one of the goals of myocardial tissue characterization is to distinguish pathologic from physiologic hypertrophy . 1nis may become possible because
Resuhs. Cyclic variation of integrated backscatter was smaller and calibrated myocardial integrated backscatter higher In patients with hypertrophied hearts than in normal subjects, but there were no significant differences in either integrated backscatter measure between patients with hypertensive hypertrophy and those with hypertrophic car iomyopathy . Transmural gradient in myocardial integrated backacatter was present only in patients with hypertrophic cardlomyopathy (5 .0 * 1 .8 dB (mean ± SDI for the septum ; 1 .2 ± 1 .6 dB for the posterior wall) .
Cor®ciusioas . Hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension can be differentiated on the basis of quantitative analysis of the transmural gradient in integrated backscatter.
(J Am Coil C ioi 1994;24:517-24) a number of experimental studies have shown that measurements of integrated ultrasonic backscatter are useful in detecting physiologic and pathologic changes in the myocardium (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Myocardial tissue characterization in human hypertrophied hearts has been attempted by a few groups (25) (26) (27) (28) (29) (30) . They clearly showed the difference in ultrasonic tissue variables between hypertrophied and normal hearts ; however, it has not been documented whether ultrasound tissue backscatter can distinguish between hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension .
In this study, we measured acoustic properties of the myocardium in patients with hypertrophied hearts to clarify whether any integrated backscatter measure may be useful in distinguishing between hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension . Therefore, calibrated myocardial integrated backscatter was measured using a newly developed M-mode format integrated backscatter imaging system capable of calibrating myocardial integrated backscatter with the power of Doppler signals from the blood . We also analyzed the transmural trend of the acoustic properties of the myocardium .
0735-10971941$7.00 Methods Ultrasound backscatter instrumentation . The integrated backscatter imaging system consisted of a commercially available echocardiograph (ME-130A, Fujitsu Co .) with a 3 .5-MHz frequency transducer, analogldigital converter and personal computer system (FMR-SOHLI, Fujitsu Co .) . Unlike a conventional imaging system, the ultrasound signals were accessed with the integrated backscatter processor to produce a continuous signal that is proportional to the logarithm of integrated backscatter. In this study, myocardial integrated backscatter was calibrated by the backscatter power from the blood . To correct for the attenuation or signal loss resulting from transmission through intervening tissue between the transducer and Doppler sample volume, the logarithmic power of Doppler signals scattering from the blood was subtracted from the logarithmic power at the area of interest in the myocardium . In this study Doppler sample volume was positioned just below the septum in the left ventricular cavity, and the area of interest for tissue characterization was positioned in the septum or posterior wall along the same interrogated beam . Characteristics of the transducer and system were adjusted beforehand using a dextran particle suspension of the known backscatter coefficient so that we could compare the amplitudes of ultrasound backscatter from the areas of interest with different depths .
Subjects . Thirty-eight patients with hypertrophied hearts were considered for this study . Three were excluded because integrated backscatter images of adequate quality could not be obtained . Therefore, the study group included 35 patients with hypertrophied hearts (29 men, 6 women ; mean e 55 years, range 14 to 80 years) . The etiology of hypertrophied hearts was considered to be hypertension in 13 patients and hypertrophic cardiomyopathy in 22 . The diagnosis of hypertrophic cardiomyopathy was based on the presence of a hypertrophied, nondilated left ventricle without a clinically defined cause . In 16 of the 22 patients with hypertrophic cardiomyopathy, asymmetric septal hypertrophy (septal/free wall thickness ratio atI .3) was present on M-mode echocardiograms . In 9 of the 22 patients with hypertrophic cardiomyopathy, an intracavitary pressure gradient, assessed with continuous wave Doppler echocardiography, was >16 mm Hg at rest, Thirty-one normal subjects (20 men, 11 women ; mean age 55 years, range 25 to 70) served as control subjects . Before the integrated backscatter studies, all subjects were examined using conventional twodimensional and M-mode echocardiography to assess chamber size, wall thickness and wall motion (Table 1) . Echocardiographie variables were measured in a standard manner from parasternal views (31) .
Data analysis . The integrated backscatter study was performed without any knowledge of patient characteristics by monitoring the two-dimensional echocardiographic image with an interrogated beam and Doppler sample volume in the right half of the display and an M-mode echocardiogram in the left half. The Doppler spectrum was monitored only by sound, not on the display . Once the toggle switch was turned to the "on" position, radiofrequency signals were converted to digital ones, and data longer than -5 s were stored in the computer memory . The integrated backscatter images were then reconstructed by the personal computer system using the stored data. On the monitor, the area of interest for backscatter measurements was traced midway between the endocardial and epicardial borders in the septum and posterior wall . We tried to exclude the thick bright lines of the endocardium and intramyocardial specular bright echoes from the area of interest . The depth of this area was 5 mm ; the trace of the center of it is indicated by a bright line .
To calibrate myocardial integrated backscatter, we determined the power of Doppler signals sampled in the left ventricular cavity as follows . The depth of the sample volume was 7 mm . In the Doppler power spectrum displayed on the computer screen, we selected by hand the intervals when signals were considered adequate for calculating Doppler power . The Doppler power averaged over the selected intervals was used for calibrating myocardial integrated backscatter . It is noteworthy that strong signals considered to have originated from the structure movement are eliminated automatically by the computer program . After placing t ;i : area of interest for backscaiter measurements in the M-mode integrated backscatter images and selecting time intervals with adequate Doppler signals in the Doppler image, the computer screen shows curves of myocardial integrated backscatter calibrated by the power of the Doppler signals . From these curves, we consistently measured two variables in all subjects . The magnitude of cyclic variation in integrated backscatter was determined as the difference between minimal and maximal peaks . The value of myocardial integrated backscatter at maximal peak was defined as the calibrated myocardial integrated backscatter at end-diastole . Averaged values over at least 3 beats were provided for quantitative analysis . Both variables are essentially independent of the transmitted ultrasound power and attenuation by the chest wall and therefore may be compared among subjects .
In addition to the averaged value of myocardial integrated backscatter in the area of interest, our system provides the values of myocardial integrated backscatter of the upper and lower halves in the area of interest . This function was used to assess the transmural trend in the measures of myocardial integrated backscatter (gradient integrated backscatter) in 21 normal subjects and in all patients with hypertrophied hearts .
Reproducibility. Interobserver and intraobserver variabilities of the measurements of the integrated backscatter variables were studied . Integrated backscatter measures were determined on screen, and variability was therefore assessed as follows . M-mode integrated backscatter images were obtained in 12 subjects by one observer . Two observers independently analyzed the integrated backscatter images to determine their variables . These were compared for determination of interobserver variability . Intraobserver variability was determined by one observer repeating the analysis process a second time in these 12 subjects for comparison with the first measurements . Mean (±SD) absolute differences of the magnitude of cyclic variation of integrated backscatter between observations were 0.7 ± 0 .4 dB (interobserver) and 0.6 ± 0 .4 dB (intraobserver) for the septum and 0 .8 ± 0.3 dB (interobserver) and 0 .5 ± 0 .4 dB (intraobserver) for the posterior wall. Mean absolute differences of the calibrated integrated backscatter at end-diastole between observations were 0 .8 ± 0 .4 dB (interobserver) and 0 .6 ± 0 .3 dB (intraobserver) for the septum and 0 .7 ± 0 .4 dB (interobserver) and 0 .5 ± 0.4 dB (intraobserver) for the posterior wall . Absolute differences of the regional calibrated integrated backscatter at end-diastole between observations were 0 .7 ± 0 .4 dB (interobserver) and 0 .6 ± 0 .3 dB (intraobserver) for the septum and 0 .7 ± 0 .5 dB (interobserver) and 0.5 ± 0 .4 dB (intraobserver) for the posterior wall .
Statistical analysis . Data are presented as mean value SID . Intergroup differences were tested for significance using analysis of variance, with subgroup analysis by the Scheffd F test . Relations between two variables were studied using a simple linear regression analysis .
Results
Integrated backscatter measures in normal subjects and patients with hypertrophied hearts . The magnitude of cyclic variation in integrated backscatter was significantly smaller and calibrated myocardial integrated backscatter significantly greater in patients with hypertrophied hearts than in normal subjects. There was no difference in either measure between patients with ventricular hypertrophy due to hypertension and those with hypertrophic cardiomyopathy (Fig . 1 , Table 1 ) .
Transmural trend of integrated backscatter measures . The magnitude of cyclic variation in integrated backscatter did not differ between the right and left ventricular halves of the septum or between the endocardial and epicardial halves of the posterior wall in all normal subjects and all patients with hypertrophy (Fig . 2, Table 2 ) . There was no significant difference in the calibrated myocardial integrated backscatter between the right and left ventricular halves of the septum or between the endocardial and epicardial halves of Table I . the posterior wall in normal subjects and patients with ventricular hypertrophy due to hypertension . In contrast, calibrated myocardial integrated backscatter was significantly greater in the right ventricular than in the left ventricular half of the septum and in the epicardial than in the endocardial half of the posterior wall, respectively, in patients with hypcrtrophic cardiomyopathy .
The transmrral trend of the calibrated myocardial integrated backscatter was quantified by calculating the difference in decibels between subendocardial and subepicardial regions . Subtracting the logarithmic decibel domain is equivalent to taking a ratio in the linear domain ; therefore our variables express the ratio of calibrated myocardial integrated backscatter in the left ventricular (endocardial) half to that in the right ventricular (epicardial) half for the septum, and the ratio of calibrated myocardial integrated backscatter in the endocardial half to that in the epicardial half for the posterior wall . The transmural gradient in integrated backscatter was significantly greater in patients with hypertrophic cardiomyopathy than in normal subjects and in patients with ventricular hypertrophy due to hypertension in both the septum and posterior wall (Fig . 3) .
Transmurall gradient in integrated backscatter and eclaocardk1pip4h4c variables . The transmural gradient in integrated backscatter was compared with ventricular wall thickness (Fig . 4) . It is again noteworthy that the transmural gradient in integrated backscatter was not observed in normal subjects and in patients with ventricular hypertrophy due to hypertension . Figure 3 . Comparison of transmuril gradient in integrated backscatter (113) among normal subjects, patients with ventricular hypertrophy due to hyperlensio., (HT) and patients with hypertrophic cardiomyopathy (11CM) in the septum (left) and posterior wall (PW) (right) . Transmural integrated backscatter gradient was significantly greater in patients with hypertrophic cardiamyopathy than in normal subjects and patients with ventricular hypertrophy due to hypertension . but there was no significant difference in this measure between normal subjects and patients with ventricular hypertrophy due to hypertension in both the septum and the posterior wall .
diomyopathy showed a positive transmural gradient in integrated backscalter in the septum, but only about half of them showed a positive transmural gradient in integrated backscatter in the posterior wall . Furthermore, the gradient was smaller in the posterior wall than in the septum (p < 0 .01). It was observed that there was no significant correlation between the transmural gradient in integrated backscatter and wall thickness in patients with hypertrophic cardiomyopathy (r = 0.12, p = NS for the septum ; r = 0 .20, p = NS for the posterior wall) . 
Discussio
Several experimental studies (15) (16) (17) (18) (19) (20) (21) (22) support the idea that both the absolute integrated backscatter and the magnitude of the cardiac cycle-dependent variation of integrated backscatter reflect the acoustic properties of the myocardium, becauic absoluke integrated backscatter increases in myocardial fibrosis (15.-17) and the magnitude of the cardiac cycle-dependent variation of integrated backscatter has been demonstrated to decrease with myocardial ischemia and infarction (19) (20) (21) (22) . Such changes in integrated backscatter measures were observed in patients with hypertrophied hearts ; however, there was no difference in either measure between ventricular hypertrophy due to hypertension and hypertrophic cardiomyopathy . Thus, we failed to distinguish between ventricular hypertrophy due to hypertension and hypertrophic cardiomyopathy by using these integrated backscatter measures. In contrast, myocardial integrated backscatter was greater in the right ventricular half than in the left ventricular half in the septum only in patients with hypertraphic cardiomyopathy, and the measurement of the transmural trend of integrated backscatter was useful in distinguishing between ventricular hypertrophy due to hypertension and hypertrophic cardiomyopathy .
Ventricular hypertrophy due to hypertension . This study showed that calibrated myocardial integrated backscatter increased significantly in patients with ventricular hypertrophy due to hypertension . Tanaka et al . (14) indicated that the percent area of fibrosis in the left ventricular wall was greater in hypertensive heart disease than in normal hearts . Myocardial fibrosis increases absolute integrated backscatter in both in vitro and in vivo experiments (15) (16) (17) 32) , and thus the possible structural changes of an increase in fibrosis of the myocardium may account for the increase in calibrated integrated backscatter in our patients with ventricular hypertrophy due to hypertension .
Cyclic variation in integrated backscatter was significantly smaller in patients with ventricular hypertrophy due to hypertension than in normal subjects . This finding is consistent with our previous finding (28) . The mechanism for this phenomenon is still unknown, but reduced regional myocardial contractile function may be the most likely explanation because the dependence of the magnitude of cardiac cyclic variation of integrated backscatter on contractile performance has been documented in experimental studies (33) (34) (35) (36) . Furthermore, regional myocardial contractile function assessed with percent systolic wall thickening was depressed in our patients with ventricular hypertrophy due to hypertension .
rRypertruphic cardioyopaft-In this study, calibrated integrated backscatter increased significantly, and the magnitude of cyclic variation in integrated backscatter decreased significantly, in patients with hypertrophic cardiomyopathy compared with normal subjects . This finding is consistent with our previous findings and those of Lattanzi et at . (28) (29) (30) were not different from those observed in patients with ventricular hypertrophy due to hypertension, and the mechanism may also be the same (i .e ., myocardial fibrosis and regional myocardial contractile function) . Although myocardial fibrosis is usually more severe in hypertrophic cardiomyopathy than in ventricular hypertrophy due to hypertension, the changes in the integrated backscatter measures were not different between these subsets . This finding suggests the possible effects of myocardial cell disor nization on these integrated backscatter measures in patients with hypertrophic cardiomyopathy . Although both integrated backscater measures failed to distinguish between hypertrophic c :=.; liomyopathy and ventricular hypertrophy due to hyperW ;,Jon in th present study, we stili believe that both inte led backscatter measures are useful to assess ventricular hypertrophy, partially because Lattanzi and colleagues showed that myocardial integrated backscatter was normal in subjects (elite athletes) with physiologic ventricular hypertrophy caused by intense physical training (301 . T trend in acoustic properties of the myocardium, The distinction between hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension was possible only with the measurements of transmural trend of integrated backscatter in our patients with hypo trophy . Transmural gradient in integrated backscatter was observed only in patients with hypertrophic cardiomyopathy . Fujiwara et al . (37) conducted histologic studies on autopsied human hearts to show that myocardial fiber disarray in patients with hypertrophic cardiomyopathy was present mostly in the middle third of the septum and in the middle and outer thirds of the posterior wall . If myocardial fiber disarray worked to increase integrated backscatter, the observed transmural gradient of integrated backscatter might be explained as the effect of the transmural nonhomogeneity of myocardial fiber disarray . The transmural gradient of integrated backscatter measure was obviously larger and more frequent in the septum than in the posterior wall in patients with hypertrophic eardiomyopathy . This finding may be also explained by the effect of the transmural nonhomogeneity of myocardial fiber disarray because this disarray is more extensive in the septum than in the posterior wall (37) (38) (39) .
The transmural gradient in integrated backscatter did not correlate with wall thickness in patients with hypertrophic cardiomyopathy either in the septum or posterior wall . Further, the transmural gradient in integrated backscatter was not observed even in patients with advanced hypertrophy due to hypertension . These findings are in contrast to the previous finding that the magnitude of variation of integrated backscatter decreases as wall thickness increases in patients with pressure overload hypertrophy, hypertrophic cardiomyopathy and cardiac transplants (28, 40) . Thus, assessment of the transmural gradient in integrated backscatter is likely to expand the use of myocardial ultrasound tissue characterization in patients with hypertrophied hearts . The abnormal acoustic properties of the myocardium may be an expression of the intrinsic myopathic process. Thus, our findings support the hypothesis that the intrinsic myopathic process involves the myocardium in a transmurally nonhomogeneous fashion, even in nonhypertrophied segments of the wall. This hypothesis is consistent with the previous findings that histologic abnormalities are observed even in segments of the wall with normal or minimally hypertrophied thickness (38, (41) (42) (43) .
Integrated bac tier in the septum versus i i, tenor wall . The present study showed the significant regional differences in calibrated myocardial integrated backscatter between the septum and posterior wall in patients with hypertrophied hearts and in normal subjects . This finding is comparable wiO those obtained by other investigators (29, 44, 45) . It may be explained by the techniques used in the determination of integrated backscatter measures and thus was observed in all subjects . Alternatively, regional differences in muscle fiber orientation may account for regional differences in acoustic properties (44) . Regional myocardial contractile function appears to be a less significant contributor to the calibrated myocardial integrated backscatter than to the magnitude of cyclic variation in integrated backscatter (28) because this measure is unaffected by an alteration of cardiac function in dogs (unpublished observations) . To exclude the possible effects of the regionality of myocardial integrated backscatter measures on the results of this study, the septum and posterior wall were analyzed separately .
Cyclic variation in integrated backscatter was slightly greater in this study than in most previous ones (46) (47) (48) . The reason for this could not be clarified but may be related to the system used . We consider this likely because in our system, integrated backscatter was determined using bandlimited rather than broad-band frequency ultrasound signals .
Technical limitations. Four technical limitations are noted . First, technically adequate integrated backscatter images were not obtained in 3 of 38 patients . Second, concerns about the accuracy and reproducibility of the evaluation of the magnitude of transmural integrated backscatter variations have been raised by the Iowa group by investigating the reproducibility of measurements for the entire process of data acquisition, including transducer placement and echocardiographic instrument adjustment, as well as longitudinal reproducibility (46) . The variance between measurements should be reduced by increasing the number of independent samples of backscatter making up each measurement . Thus, the use of M-mode rather than twodimensional imaging and the use of a relatively small area of interest were factors that could possibly reduce the reproducibility and reliability of the integrated backscatter measures . In addition, translational and rotational movements of the heart should affect the integrated backscatter measures . Thus, intraobserver and interobserver reproducibility were evaluated in this study . Our data showed that any of our integrated backscatter measures, including regional (endocardial and epicardial) measures, could be obtained as reliably and reproducibly as those in many earlier studies (28, 44, 47, 48 . Thus, the mean values of the transmural difference (or gradient) in integrated backscatter of 5 dB in patients with hypertrophic cardiomyopathy cannot be explained solely by the error due to possible problems with respect to the accuracy and reproducibility of ultrasound backscatter measurements .
Third, all quantitative analysis was based on the integrated backscatter values determined by hand tracing the area of interest on the integrated backscatter image, and there are problems inherent in the measurements (28, 40, 47) . Thick, bright echo lines of the right or left septal endocardium, intramyocardial septal specular bright echoes or both may have affected the integrated backscatter measures in some patients . The depth of the area of interest was 5 trim in both normal subjects and patients with hypertrophy, and the thick bright lines of septal endocardium prevented us from tracing the midportion of the septum, particularly in normal subjects with a relatively thin wall . Although this is likely to lead to a reduced signal-to-noise ratio or an increase in the integrated backscatter value not related to changes in the acoustic properties of the myocardium, our current system is capable of eliminating far stronger signals from the computation of integrated backscatter . Thus, the effects of the thick bright lines of septal endocardium and intramyocardial specular bright echoes were minimized in our current system . Finally, ultrasound backscatter is affected by the orientation of myocardial fibers and therefore is view dependent (49, 50) . Thus, our transmural as well as regional evaluation of integrated backscatter can be performed only in the limited region of the septum and posterior wall imaged in the parasternal views . Although our methods cannot be used to assess noninvasively the extent of abnormal acoustic properties of the myocardium, the most frequent site of hypertrophy is the septum, and this cannot be considered a serious limitation of the present study .
Clinical implications and conclusions. This study showed clearly that an analysis of the transmural trend of the myocardial integrated backscatter may be useful in distinguishing between hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension . Hypertrophic cardiomyopathy, in most cases, is characterized by asymmetric septal hypertrophy (3) (4) (5) (6) 51) , and thus conventional echocardiography is useful in both the quantification of hypertrophy and the differentiation of this disease from pressure overload hypertrophy . The difference between these two types of hypertrophy in the adult, however, is identified most clearly by histologic analysis, with myocyte disarray observed mostly in the septum in hypertrophic cardiomyopathy and myocardial fibrosis observed in both conditions . Because the transmural trend of myocardial integrated backscatter was observed exclusively in patients with hypertrophic cardiomyopathy, this tissue characterization measure appears to provide a promising noninvasive method for assessing the difference between hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension . Although hypertrophic cardiomyopathy and ventricular hypertrophy due to NAITO ET AL. 5 23 MYOCARDIAL TISSUE CHARACTERIZATION hypertension may be considered separate entities, their association continues to be a topic of debate (52) . The use of myocardial ultrasound tissue characterization may allow practitioners to gain further insight into this issue .
Differentiation of cardiomyopathy from ventricular hypertrophy due to hypertension was accomplished with the use of the endocardiallepicardial ratio of myocardial integrated backscatter . It has been noted that this determination does not need a calibration method because myocardial integrated backscatter in the halves of the wall determined with a relative scale may be used for this calculation . As long as the scale is the same, the endocardial/epicardial ratio is determined properly, We thank Akira Shiha, MS, Keiichi Murakami, MS, and Takaki Shimura, MS, of Fujitsu Laboratory Corporation for advice and modification of the equipment .
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